Skip to main content
Print Save

Logo (Actavis) 155 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base))

Pill with imprint Logo (Actavis) 155 is White, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base). It is supplied by Actavis Elizabeth LLC.

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for Logo (Actavis) 155

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base) Logo (Actavis) 155
Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base) Logo (Actavis) 155

Save up to 80% off prescription medications

Click here for your free Discount Card

Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)

Imprint
Logo (Actavis) 155
Strength
8 mg (base) / 2 mg (base)
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Actavis Elizabeth LLC
National Drug Code (NDC)
00228-3155 (Discontinued)
Inactive Ingredients
citric acid anhydrous, lactose monohydrate, magnesium stearate, mannitol, corn starch, povidone k30, trisodium citrate dihydrate, sucralose

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer